Head-to-head · Value Score
CoreAge Rx vs Oak
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Oak a 56. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameOak
#377 · Grade C · Watch List
Est. first month
$250/mo semaglutide · $300/mo tirzepatide (one flat rate at every dose), read the afternoon of 15 August; both were $50 lower that morning
The verdict
CoreAge Rx takes it on Value Score, 93 to 56 — an est. $99/mo first month, with no teaser step-up baked in. Oak isn't out of it: People who want all-50-state coverage without a recurring commitment and are willing to complete a long intake before finding out what they will be charged.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Oak |
|---|---|---|
| Value Score | 93 (A+) | 56 (C) |
| Est. first month | $99/mo | $250/mo semaglutide · $300/mo tirzepatide (one flat rate at every dose), read the afternoon of 15 August; both were $50 lower that morning |
| Save vs brand-name | ~89% | — |
| Semaglutide | $99/mo | $250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning |
| Tirzepatide | $149/mo | $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Oak
Nationwide coverage and no subscription to cancel, at $200/mo for compounded semaglutide and $250 for tirzepatide — one flat rate at every dose. Its advertising is the problem: nine different "starting" prices, not one of which comes with a term or is what it charges.
Why it's a deal
- All 50 states, offered in Spanish as well as English, with free shipping
- No membership or subscription fee — Oak sells packages rather than a recurring plan, so there is nothing to cancel
- Both compounded molecules are offered, and Oak states that all doses are the same price, so titrating up would not raise the bill if that holds
- Same-day approval, which is genuinely fast if speed is what you are optimizing for
The fine print
- Its published price is not stable enough to compare on — its order form moved by $50 inside a single day: $200/mo semaglutide and $250 tirzepatide on the morning of 15 August 2026, $250 and $300 that afternoon on the same page with browser storage cleared, every brand line $100 higher and the discount strike-throughs gone
- No usable price. Oak publishes nine conflicting "starting" figures across its own pages — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term or billing cadence to none of them, so none can be compared against anything in this ranking
- The two cheapest figures are not monthly rates. $119 and $185 appear only beside a "$200 off" new-patient offer, and Oak's own wording for that offer is "$50 off your first month, $200 off 3-months" — a three-month package discount
- Its own undiscounted floors contradict each other: $190/mo on the weight-loss page and $167/mo in the comparison table on its front page, on the same site, on the same day
- Its advertising and its order form disagree: none of the nine "starting" figures it markets is the $200/$250 it actually charges, so comparing Oak on its advertised numbers compares it against a price it does not offer
- "All doses are the same price" is Oak's claim and we could not confirm it — a reading of its checkout copy recorded each dose step costing roughly $50–$75 more, and resolving that would require submitting the intake
- Same-day approval with no video call means very little clinical contact before a prescription
- Injection only — no oral or sublingual route, and no brand-name lane
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Oak.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.